Cargando…

Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson’s disease

Context: Safranal (SAF) is verified to have potential effects in promoting nerve growth. Objectives: This study verifies the role of SAF in promoting dopaminergic neurons growth in vitro and in vivo. Material and methods: Rat neural stem cells (NSC) were treated with 1, 20, or 100 ng/mL of SAF, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yi, Xi, Gangming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201804/ https://www.ncbi.nlm.nih.gov/pubmed/30354840 http://dx.doi.org/10.1080/13880209.2018.1501705

Ejemplares similares

Dose‐dependent effect of mesenchymal stromal cells co‐grafted with dopaminergic neurons in a Parkinson's disease rat model
por: Rodriguez‐Pallares, Jannette, et al.
Publicado: (2021)

Induced dopaminergic neurons: A new promise for Parkinson’s disease
por: Xu, Zhimin, et al.
Publicado: (2017)

Ultrasound-assisted extraction of saffron bioactive compounds; separation of crocins, picrocrocin, and safranal optimized by artificial bee colony
por: Sarfarazi, Messiah, et al.
Publicado: (2022)

Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease
por: Guatteo, Ezia, et al.
Publicado: (2022)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

The legacy of Jeremy Safran
por: Lingiardi, Vittorio, et al.
Publicado: (2019)

Parkinson’s disease: animal models and dopaminergic cell vulnerability
por: Blesa, Javier, et al.
Publicado: (2014)

DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease
por: Barallobre, M J, et al.
Publicado: (2014)

Dispensable role of Drosophila ortholog of LRRK2 kinase activity in survival of dopaminergic neurons
por: Wang, Danling, et al.
Publicado: (2008)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

The differentiation of human placenta-derived mesenchymal stem cells into dopaminergic cells in vitro
por: Chen, Li, et al.
Publicado: (2009)

Selenoprotein T Exerts an Essential Oxidoreductase Activity That Protects Dopaminergic Neurons in Mouse Models of Parkinson's Disease
por: Boukhzar, Loubna, et al.
Publicado: (2016)

Whole-genome DNA hyper-methylation in iPSC-derived dopaminergic neurons from Parkinson’s disease patients
por: Fernández-Santiago, Rubén, et al.
Publicado: (2019)

The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
por: Karuppagounder, Senthilkumar S., et al.
Publicado: (2014)

Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson’s model
por: Pradhan, Priyadarshika, et al.
Publicado: (2020)

Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson’s Disease
por: Lin, Jaung-Geng, et al.
Publicado: (2017)

Conditional deficiency of m6A methyltransferase Mettl14 in substantia nigra alters dopaminergic neuron function
por: Teng, Yan, et al.
Publicado: (2021)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Affinity-based target deconvolution of safranal
por: Hosseinzadeh, Hossein, et al.
Publicado: (2013)

Jeremy Safran: a hero’s journey
por: Horvath, Adam Otto
Publicado: (2019)

Pharmacological effects of Safranal: An updated review
por: Esmaealzadeh, Danial, et al.
Publicado: (2023)

Graphene Oxide and Reduced Derivatives, as Powder or Film Scaffolds, Differentially Promote Dopaminergic Neuron Differentiation and Survival
por: Rodriguez-Losada, Noela, et al.
Publicado: (2020)

Neuroprotective Effect and Mechanism of Thiazolidinedione on Dopaminergic Neurons In Vivo and In Vitro in Parkinson's Disease
por: Wang, Yanqin, et al.
Publicado: (2017)

Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
por: Wang, Ronglin, et al.
Publicado: (2018)

The netrin‐1 receptor DCC promotes the survival of a subpopulation of midbrain dopaminergic neurons: Relevance for ageing and Parkinson’s disease
por: Lo, Pik‐Shan, et al.
Publicado: (2022)

The Relaxant Activity of Safranal in Isolated Rat Aortas is Mediated Predominantly via an Endothelium-Independent Mechanism: -Vasodilatory mechanism of safranal-
por: Razavi, Bibi Marjan, et al.
Publicado: (2016)

Cell-penetrating, antioxidant SELENOT mimetic protects dopaminergic neurons and ameliorates motor dysfunction in Parkinson's disease animal models
por: Alsharif, Ifat, et al.
Publicado: (2020)

Corynoxine Protects Dopaminergic Neurons Through Inducing Autophagy and Diminishing Neuroinflammation in Rotenone-Induced Animal Models of Parkinson’s Disease
por: Chen, Leilei, et al.
Publicado: (2021)

Roles of FGF20 in dopaminergic neurons and Parkinson's disease
por: Itoh, Nobuyuki, et al.
Publicado: (2013)

Chemical and Biological Molecules Involved in Differentiation, Maturation, and Survival of Dopaminergic Neurons in Health and Parkinson’s Disease: Physiological Aspects and Clinical Implications
por: Gaggi, Giulia, et al.
Publicado: (2021)

Ruptures, repairs, and reflections: contributions of Jeremy Safran
por: Samstag, Lisa Wallner, et al.
Publicado: (2019)

Human midbrain dopaminergic neuronal differentiation markers predict cell therapy outcomes in a Parkinson’s disease model
por: Xu, Peibo, et al.
Publicado: (2022)

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
por: Bengoa-Vergniory, Nora, et al.
Publicado: (2020)

Irisin protects the substantia nigra dopaminergic neurons in the rat model of Parkinson’s disease
por: Zarbakhsh, Sam, et al.
Publicado: (2019)

Src Inhibition Attenuates Neuroinflammation and Protects Dopaminergic Neurons in Parkinson’s Disease Models
por: Yang, Hanyu, et al.
Publicado: (2020)

Assessment of dopaminergic neuron degeneration in a C. elegans model of Parkinson’s disease
por: Palikaras, Konstantinos, et al.
Publicado: (2022)

Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson’s disease
por: Tönges, Lars, et al.
Publicado: (2012)

Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
por: Kojovic, Maja, et al.
Publicado: (2014)

Striatal astrocytes engulf dopaminergic debris in Parkinson's disease: A study in an animal model
por: Morales, Ingrid, et al.
Publicado: (2017)

Dopaminergic Neuronal Imaging in Genetic Parkinson's Disease: Insights into Pathogenesis
por: McNeill, Alisdair, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m35eugn7fssjvu4fk8i9pkplca